Reuters logo
BRIEF-Cascadian Therapeutics reports Q3 loss per share $0.09
November 7, 2016 / 10:17 PM / 10 months ago

BRIEF-Cascadian Therapeutics reports Q3 loss per share $0.09

Nov 7 (Reuters) - Cascadian Therapeutics Inc

* Cascadian Therapeutics - estimates that its cash, cash-equivalents and investments will be sufficient to fund operations for at least next 12 months

* Cascadian Therapeutics reports third quarter 2016 financial results and provides corporate update

* Q3 loss per share $0.09

* Q3 earnings per share view $-0.08 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below